Hem › Crohns sjukdom › Texas › Tyler
Kliniska studier för Crohns sjukdom i Tyler, TX
16 studier för Crohns sjukdom söker deltagare vid platser i och runt Tyler (inom ca 30 miles). Öppna en studie för att se vem som kan delta och hur du kontaktar studieteamet.
Officiell studietext (engelska)
Rekryterar du till en studie? Visa den högst upp på sidan – $99 i 30 dagar →
Extension Study of Long-term Safety and Efficacy of Tulisokibart in Participants With Crohn's Disease or Ulcerative Colitis (MK-7240-011)
RekryterarFas 3
- Tyler Research Institute ( Site 0294), Tyler
A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)
RekryterarFas 3
- Tyler Research Institute ( Site 5001), Tyler
Study of Targeted Therapies for the Treatment of Adult Participants With Moderate to Severe Crohn's Disease
RekryterarFas 2
- Tyler Research Institute /ID# 265545, Tyler
A Study of Guselkumab Versus Risankizumab in Participants With Moderately to Severely Active Crohn's Disease
RekryterarFas 3
- The University of Texas Health Science Center at Tyler, Tyler
A Study of Icotrokinra in Participants With Moderately to Severely Active Crohn's Disease
RekryterarFas 2/3
- Tyler Research Institute, LLC, Tyler
A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Crohn's Disease
RekryterarFas 2
- Tyler Research Institute, LLC, Tyler
Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight
RekryterarFas 3
- Tyler Research Institute, Tyler
An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease
RekryterarFas 3
- Tyler Research Institute, LLC-Site Number: 8400095, Tyler
A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease
RekryterarFas 3
- Tyler Research Institute LLC-Site Number: 8400095, Tyler
A Phase 2 Study to Evaluate MORF-057 in Adults With Moderately to Severely Active Crohn's Disease
RekryterarFas 2
- Tyler Research Institute, LLC, Tyler
A Study of Vedolizumab Intravenous (IV) and Adalimumab or Vedolizumab and Ustekinumab in Adults With Crohn's Disease
RekryterarFas 4
- Tyler Research Institute, LLC, Tyler
A Study of JNJ-78934804 in Participants With Moderately to Severely Active Crohn's Disease
RekryterarFas 3
- Tyler Research Institute, LLC, Tyler
A Study of Vedolizumab With and Without Upadacitinib in Adults With Crohn's Disease
RekryterarFas 3
- Tyler Research Institute, LLC, Tyler
A Continuation Study of TAK-279 in Adults With Ulcerative Colitis (UC) and Crohn's Disease (CD)
RekryterarFas 2
- Tyler Research Institute, LLC, Tyler
Efficacy and Safety of Obefazimod in Subjects With Moderately to Severely Active Crohn's Disease
RekryterarFas 2
- Tyler Research Institute, LLC, Tyler
A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease
RekryterarFas 2
- Mirador Therapeutics Selected Site, Tyler
Crohns sjukdom-studier i andra städer
- New York City, NY35 studier
- Cleveland, OH19 studier
- St. Louis, MO19 studier
- Boston, MA19 studier
- Miami, FL19 studier
- Orlando, FL17 studier
- Houston, TX17 studier
- Atlanta, GA17 studier
- San Diego, CA15 studier
- San Antonio, TX15 studier
- Los Angeles, CA15 studier
- Philadelphia, PA13 studier
Andra studier i Tyler
- Icke-småcellig lungcancer20 studier
- Ulcerös kolit14 studier
- Kolorektal cancer8 studier
- Hjärtsvikt8 studier
- Cancer (alla typer)7 studier
- Äggstockscancer7 studier
- Endometriecancer6 studier
- Plattenepitelcancer i huvud och hals6 studier
- Bröstcancer6 studier
- Metastaserande cancer5 studier
- Inflammatorisk tarmsjukdom5 studier
- Kronisk lymfatisk leukemi5 studier
Från ClinicalTrials.gov, data hämtad 5 okt. 2026. Varje studie har egna kvalifikationskrav; studieteamet avgör vem som kan delta.